首页> 外文期刊>Urology >Technetium-99m-L,L-ethylenedicysteine is more effective than technetium-99m diethylenetriamine penta-acetic acid for excluding obstruction in patients with pyelocalicinal dilation.
【24h】

Technetium-99m-L,L-ethylenedicysteine is more effective than technetium-99m diethylenetriamine penta-acetic acid for excluding obstruction in patients with pyelocalicinal dilation.

机译:net 99m-L,L-乙二炔半胱氨酸比net 99m二亚乙基三胺五乙酸更有效地排除局部局部扩张患者的阻塞。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To evaluate the utility of diuretic dynamic renal scintigraphy (DDRS) with technetium-99m-L,L-ethylenedicysteine ((99m)Tc-EC) in patients with indeterminate or possible false-positive results for urinary obstruction by technetium-99m diethylenetriamine penta-acetic acid ((99m)Tc-DTPA) DDRS. METHODS: A total of 92 patients (63 male; mean age, 16.6 +/- 21.25 years) were studied, with a total of 103 kidneys presenting indeterminate (20/103) or possible false-positive results for obstruction attributable to reduced renal function or severe kidney dilation (83/103) by (99m)Tc-DTPA DDRS (<60% of radiopharmaceutical excreted in 20 minutes-half-time clearance [T(1/2)] >15 minutes). Patients were reimaged after intravenous injection of (99m)Tc-EC, with dynamic images before and after furosemide administration using the same acquisition parameters applied in the previous (99m)Tc-DTPA study. Time interval between (99m)Tc-DTPA and (99m)Tc-EC renograms was 2-64 days. The percentage of excreted material 20 minutes after furosemide was calculated using both radiopharmaceuticals, and were statistically compared using the paired samples t test. RESULTS: The excretion after furosemide injection was 25.3% +/- 18.2% for (99m)Tc-DTPA and 41.2% +/- 26.1% for (99m)Tc-EC, with a statistically significant difference between both radiopharmaceuticals (P <.0001). Using (99m)Tc-EC obstruction was excluded in 36 of 103 kidneys, which excreted >60%. A total of 10 of 83 kidneys (12.0%) with an obstructive pattern by (99m)Tc-DTPA study turned out to be indeterminate by (99m)Tc-EC DDRS. There was an agreement between (99m)Tc-EC and (99m)Tc-DTPA studies in 54 of 83 kidneys with obstructive (65.1%) and in 3 of 20 (15.0%) with indeterminate patterns. CONCLUSIONS: (99m)Tc-EC was more effective than (99m)Tc-DTPA for excluding obstruction, presenting less false-positive and indeterminate results. (99m)Tc-EC can substitute (99m)Tc-DTPA to evaluate patients with urinary tract dilation.
机译:目的:评价使用tech 99m-L,L-乙二炔半胱氨酸((99m)Tc-EC)的利尿剂动态肾闪烁显像(DDRS)在tech 99m二亚乙基三胺引起的尿路梗阻不确定或可能存在假阳性结果的患者中的用途五乙酸((99m)Tc-DTPA)DDRS。方法:共研究了92例患者(63例男性;平均年龄为16.6 +/- 21.25岁),共有103例肾功能不全(20/103)或可能因肾功能减退而可能出现假阳性结果的肾脏或(99m)Tc-DTPA DDRS导致的严重肾脏扩张(83/103)(<60%的放射性药物在20分钟半清除后[T(1/2)]> 15分钟内排泄)。静脉注射(99m)Tc-EC后,使用速尿之前和之后(99m)Tc-DTPA研究中使用的相同采集参数,在使用呋塞米之前和之后对患者进行动态成像。 (99m)Tc-DTPA和(99m)Tc-EC肾图之间的时间间隔为2-64天。使用两种放射性药物计算呋塞米20分钟后排泄物质的百分比,并使用配对样本t检验进行统计学比较。结果:(99m)Tc-DTPA注射速尿后的排泄率为25.3%+/- 18.2%,(99m)Tc-EC的排泄率为41.2%+/- 26.1%,两种放射性药物之间的统计学差异显着(P <。 0001)。 103个肾脏中有36个肾脏排除了使用(99m)Tc-EC阻塞,其排泄> 60%。 (99m)Tc-DTPA研究显示,共有83个肾脏中有10个阻塞了肾脏(12.0%),结果被(99m)Tc-EC DDRS所确定。 (99m)Tc-EC和(99m)Tc-DTPA研究在83例阻塞性肾脏病中的54例(65.1%)和20例不确定性肾脏病中的20例(15.0%)中达成了共识。结论:(99m)Tc-EC在排除梗阻方面比(99m)Tc-DTPA更有效,假阳性和不确定结果较少。 (99m)Tc-EC可以替代(99m)Tc-DTPA来评估尿路扩张的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号